SCHEMBL25993409

SCHEMBL25993409

Cn1c2ccccc2c2ccc3sc4cccc(-c5ccccc5)c4c3c21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALKBH5 Q6P6C2 1/20 0.44
▸ FTO Q9C0B1 1/20 0.44
▸ HSD17B10 Q99714 3/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ IDO1 P14902 1/20 0.40
▸ GPR3 P46089 1/20 0.39
▸ RET P07949 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ MAPK14 Q16539 1/20 0.36
▸ HPGD P15428 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ LIMK1 P53667 1/20 0.35
▸ F9 P00740 1/20 0.35
▸ RXRA P19793 1/20 0.34
▸ RXRB P28702 1/20 0.34
▸ LMNA P02545 2/20 0.34
▸ MAOB P27338 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25681859 0.86 HSD17B10 (0.37) ALKBH5FTOHSD17B10HSP90AA1IDO1
SCHEMBL25681897 0.85 HSD17B10 (0.33) ALKBH5FTOHSD17B10HSP90AA1IDO1
SCHEMBL13183686 0.82 ALKBH5 (0.49) ALKBH5FTOHSD17B10HSP90AA1IDO1
SCHEMBL25681880 0.82 RXRA (0.42) ALKBH5FTOHSD17B10HSP90AA1IDO1
SCHEMBL25681896 0.82 RXRA (0.42) ALKBH5FTOHSD17B10HSP90AA1IDO1
SCHEMBL25681857 0.81 F9 (0.39) ALKBH5FTOHSD17B10GPR3MAPT
SCHEMBL25681851 0.79 MAOB (0.47) ALKBH5FTOHSD17B10HSP90AA1IDO1
SCHEMBL25682598 0.79 ALKBH5 (0.44) ALKBH5FTOHSD17B10HSP90AA1IDO1
SCHEMBL25993634 0.79 ALKBH5 (0.44) ALKBH5FTOHSD17B10HSP90AA1IDO1
SCHEMBL18015005 0.78 ALKBH5 (0.56) ALKBH5FTOHSD17B10HSP90AA1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-08-24 — — US disclosed
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-08-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT CRY1, CCNE2, CRY2 ALKBH5 2658/4885FTO 1081/4885HSD17B10 1375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback